Athanor Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Athanor Capital’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53,426	Closed	-$525K	–	218
2021 Q3	$525K	Sell	53,426 -9,837	-16%	-$8.83K	0.07%	193
2021 Q2	$617K	Sell	63,263 -4,407	-7%	-$4.4K	0.02%	285
2021 Q1	$673K	Buy	+67,670	New	+$114K	0.02%	419

Other funds holding FLACW

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32M AUM 108.13% 1-Year Est. Return

MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return

Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Athanor Capital's FLACW Position: Q4 2021 in Review

Athanor Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2021, closing a stake of 53,426 shares — an estimated $525K sold.

Athanor Capital first reported a position in FLACW in Q1 2021 and held it in 3 quarters. The position peaked at $673K in Q1 2021. 29 funds tracked by Wall St. Rank hold FLACW as of Q4 2021.

Athanor Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2021 after selling out during the quarter.
Athanor Capital sold 53,426 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2021, an estimated $525K.
Athanor Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q1 2021 and held it in 3 quarters.
Athanor Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $673K in Q1 2021.
29 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2021.

Based on Athanor Capital's 13F filing for Q4 2021, filed 14 Feb 2022.